Trial Profile
A Study to Evaluate the Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2017
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- Sponsors Changchun Keygen Biological Products
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2013 New trial record